Programme

Room N101B
2025-07-05
09:00-10:30
State Key Lab Meeting (1): Microbiome and Cancer
Chair : Markus GERHARD, Joseph SUNG
09:00
To be confirmed
09:25
Using genetics to explore microbe-host interactions at the molecular level
09:50
Gut microbiome dynamics in MASLD: Implications for liver cancer
10:15
Q & A
Room N101B
2025-07-05
11:00-12:30
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
Chair : Kwan MAN, Nathalie WONG
11:00
Portal hypertensive enteropathy – From bench to bedside
11:25
Novel agents to treat MASLD
11:50
Bridging the gap: The future of cancer research and Clinical Oncology
12:15
Q&A
Room N101B
2025-07-05
12:30-14:00
Lunch Symposium (B)
12:30
Lunch Symposium
13:00
Personalized treatment of Crohn's Disease (CD) – How to optimize the use of biologics?
13:50
Q&A
Room N101B
2025-07-05
15:50-17:20
Hepatology Session (1): Viral Hepatitis
Chair : Henry CHAN, Grace WONG
15:50
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
16:15
Long-term safety of oral nucleos(t)ide analogues
16:40
The road to 2030: Can Asia achieve viral hepatitis elimination?
17:05
Q & A
Room N101B
2025-07-05
17:20-18:20
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
Chair : Jian-gao FAN, Vincent WONG
17:20
New insights on the natural history of MASLD: From the intricate interaction with other metabolic diseases to burning out MASH
17:45
Are incretin therapies the definitive solution for MASH?
18:10
Q & A
Room N111 & 12
2025-07-06
10:20-11:30
Greater China Meeting (7)
Chair : Ying-xuan CHEN, I-chen WU, Xue-mei LIU
10:20
VCTE
10:40
Primary biliary cholangitis: Diagnosis and management
11:00
Insights into the diagnosis and evaluation of NAFLD/MAFLD: Update of China guidelines
11:20
Discussion Session
State Key Lab Meeting (1): Microbiome and Cancer
Room N101B
2025-07-05
09:00
Chair : Markus GERHARD, Joseph SUNG
09:00
To be confirmed
09:25
Using genetics to explore microbe-host interactions at the molecular level
09:50
Gut microbiome dynamics in MASLD: Implications for liver cancer
10:15
Q & A
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
Room N101B
2025-07-05
11:00
Chair : Kwan MAN, Nathalie WONG
11:00
Portal hypertensive enteropathy – From bench to bedside
11:25
Novel agents to treat MASLD
11:50
Bridging the gap: The future of cancer research and Clinical Oncology
12:15
Q&A
Lunch Symposium (B)
Room N101B
2025-07-05
12:30
12:30
Lunch Symposium
13:00
Personalized treatment of Crohn's Disease (CD) – How to optimize the use of biologics?
13:50
Q&A
Hepatology Session (1): Viral Hepatitis
Room N101B
2025-07-05
15:50
Chair : Henry CHAN, Grace WONG
15:50
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
16:15
Long-term safety of oral nucleos(t)ide analogues
16:40
The road to 2030: Can Asia achieve viral hepatitis elimination?
17:05
Q & A
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
Room N101B
2025-07-05
17:20
Chair : Jian-gao FAN, Vincent WONG
17:20
New insights on the natural history of MASLD: From the intricate interaction with other metabolic diseases to burning out MASH
17:45
Are incretin therapies the definitive solution for MASH?
18:10
Q & A
Greater China Meeting (7)
Room N111 & 12
2025-07-06
10:20
Chair : Ying-xuan CHEN, I-chen WU, Xue-mei LIU
10:20
VCTE
10:40
Primary biliary cholangitis: Diagnosis and management
11:00
Insights into the diagnosis and evaluation of NAFLD/MAFLD: Update of China guidelines
11:20
Discussion Session